Increased HIV‐1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms is a research paper published in American Journal of Reproductive Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI152118
NICHD NIH HHS
Grant: R01 HD083026
National Institutes of Health
Grant: 5R01HD083026-05
Combination treatment for protection against HIV1 and pregnancy
National Institutes of Health
Grant: 5R01AI152118-04
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals